RNVA Stock Overview
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rennova Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNVA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 1.0% |
| 1Y | 0% | 2.2% | 21.9% |
Return vs Industry: RNVA underperformed the US Healthcare industry which returned 3.4% over the past year.
Return vs Market: RNVA underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| RNVA volatility | |
|---|---|
| RNVA Average Weekly Movement | 7,213.9% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RNVA's share price has been volatile over the past 3 months.
Volatility Over Time: RNVA's weekly volatility has decreased from 8280% to 7214% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 107 | Seamus Lagan | www.rennovahealth.com |
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.
Rennova Health, Inc. Fundamentals Summary
| RNVA fundamental statistics | |
|---|---|
| Market cap | US$2.97m |
| Earnings (TTM) | US$2.38m |
| Revenue (TTM) | US$20.30m |
0.0x
P/E Ratio0.0x
P/S RatioIs RNVA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNVA income statement (TTM) | |
|---|---|
| Revenue | US$20.30m |
| Cost of Revenue | US$7.49m |
| Gross Profit | US$12.81m |
| Other Expenses | US$10.44m |
| Earnings | US$2.38m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 63.10% |
| Net Profit Margin | 11.70% |
| Debt/Equity Ratio | -42.1% |
How did RNVA perform over the long term?
See historical performance and comparison